Sunday 05 November 2017

Similar documents
ICREA-FIJC ACROSS TUMOR HETEROGENEITY AND EVOLUTION IN CANCER: FROM IN SILICO STUDIES TO CLINICAL IMPACT

Conference Program. Genomic heterogeneity in localized lung cancer Andrew Futreal, The University of Texas MD Anderson Cancer Center, Houston, TX

Invited Journal: Nature Medicine. Sponsors: Thermo Fisher Novocure Merck. Venue: Spanish National Cancer Research Centre CNIO Auditorium Madrid, Spain

Immunogenomics of disease: accelerating to patient benefit. Conference Programme

PDX MODELS IN CLINICAL ONCOLOGY AND CANCER PRECISION MEDICINE 3-5 OCTOBER Seminar-Hotel Rigi am See Weggis Switzerland

CRC 992 Symposium on Medical Epigenetics 2018

Immunoreceptors and Immunotherapy

Registration Continental Breakfast. Histone Modifications and Cancer- Part 1

2016 CRUK Lung Cancer Centre of Excellence Student/Postdoc Winter Workshop Programme

PROGRAM RNA The Nineteenth Annual Meeting of the RNA Society Quebec City, Canada June 03 08, 2014

The Challenge of Chronic Pain 4-6 March Wellcome Genome Campus, Hinxton, Cambridge, UK

Course Organizers: Neal Copeland, Ph.D., The Houston Methodist Research Institute Nancy Jenkins, Ph.D., The Houston Methodist Research Institute

CNIO- la Caixa Foundation Frontiers Meeting- 2nd-4th MAY 2017 MOLECULAR CHAPERONES IN CANCER

VENUE. NMI Natural and Medical Sciences Institute at the University of Tübingen. Markwiesenstrasse 55, Reutlingen, Germany

Exploring Human Host-Microbiome Interactions in Health and Disease 5-7 December 2018

PROGRAM. Educational Session: Genomics 15:00-17:00 Session Chair: Lillian L. Siu, Princess Margaret Cancer Centre, Toronto, ON, Canada

Thursday 02 February 2017

DFG. DFG Hinterzartener Kreis für Krebsforschung. From Molecular Mechanisms to Cancer Therapy. May 15-18, 2014 Villa La Collina Cadenabbia (Co), Italy

OVARIAN. CANCER Optimal Therapy. Update ADVANCED. 12 th International Symposium. Valencia, 22 nd February

Whole Genome and Transcriptome Analysis of Anaplastic Meningioma. Patrick Tarpey Cancer Genome Project Wellcome Trust Sanger Institute

Advances in Breast Cancer Research: Genetics, Biology, and Clinical Applications

Day 0 Sunday, July 8: Arrivals. Day 1 Monday, July 9: Introduction, Fundamentals, and Germline Variation. *As of 6/29/18

Speakers. Text to be added

HCC and the Hallmarks of Cancer: steps towards novel therapeutic strategies

Welcome Remarks and Session Chair: Anil Rustgi, University of Pennsylvania, Philadelphia, PA

David Tamborero, PhD

Human Genetics 542 Winter 2018 Syllabus

Sunday, October 26 th

Human Genetics 542 Winter 2017 Syllabus

FEBS 2019 Advanced Lecture Course. Biological Surfaces and Interfaces: The Mechanistic View.

Cancer Genomics. Nic Waddell. Winter School in Mathematical and Computational Biology. July th

ESMO-ESO Course on Medical Oncology for Medical Students Educational Programme July 2016, Valencia, Spain

SEVENTH INTERNATIONAL WORKSHOP ON DOSIMETRY FOR RADIATION PROCESSING

Course in Cancer Metabolism

8:30-9:00 Increased dependence on glutamine in PTEN-deficient breast cancer Ramon E. Parsons, Icahn School of Medicine at Mount Sinai, New York, NY

OECD WORKSHOP 2000 ON HEALTHY AGEING AND BIOTECHNOLOGY RESEARCH AND POLICY ISSUES

4 TH International LFS Association Symposium

GLOBAL SYMPOSIUM ON DIETARY THERAPIES FOR EPILEPSY & OTHER NEUROLOGICAL DISORDERS

EULAR-PReS PAEDIATRIC MUSCULOSKELETAL COURSE. Monday 12th Wednesday 14th June 2017 Madrid, Spain

Advancing today s research; Fostering tomorrow s leaders

Emerging Data on the Role of Wnt Biology in Cancer

International workshop NO-CANCER 2017 From Cancerogenesis to Therapy: new paradigms, new opportunities

Madrid March Manuel Hidalgo. Alberto Bardelli. Lillian Siu. Josep Tabernero. Application deadline February 23 rd

Liposarcoma*Genome*Project*

US AARH AIAS SYMPOSIUM

8 th course on NON-CODING GENOME February 13-20, 2019 Institut Curie - Training Unit - International Course

Fish Muscle Growth and Repair: Models Linking Biomedicine and Aquaculture

Clinical Cytogenetics September 14 th 20 th, 2014 Goldrain, South Tyrol, Italy

Introduction to Cancer Biology

SPONSORSHIP OPPORTUNITIES

DFG. DFG Hinterzartener Kreis für Krebsforschung. From Molecular Mechanisms to Targeted Cancer Therapy

Wednesday 27 June Talks in Stripe Auditorium Catering breaks, exhibition and poster viewing in Stripe Lecture Room, Stripe Studio 1 and 2

This meeting has been made possible by an independent grant from Roche.

Molecularly Targeted Therapies: Mechanisms of Resistance

Summary... 2 TRANSLATIONAL RESEARCH Tumour gene expression used to direct clinical decision-making for patients with advanced cancers...

Sunday 2 Monday 3 Tuesday 4 Wednesday 5. Presentation from Merck, followed by Lunch End of conference

SAVE THE DATE FOR THE 2019 AIRR COMMUNITY MEETING. Bridging the Gaps MAY 2019, Genoa, Italy

Hinterzartener Kreis der DFG für Krebsforschung. From Molecular Mechanisms to Cancer Therapy

The 100,000 Genomes Project

Session 6: Integration of epigenetic data. Peter J Park Department of Biomedical Informatics Harvard Medical School July 18-19, 2016

International Symposium on the Ehlers-Danlos Syndromes

3 rd course on BREAST CANCER: FROM CLINICS TO BIOLOGY June 19-23, 2017 Institut Curie - Training Unit - International Course

Starr Cancer Consortium Retreat Cold Spring Harbor Laboratory, May 1-2, 2017 Monday, May 1, 2017

From stem cells to human development

ORGANISING COMMITTEE

Session Chair: Lynette Denny, University of Cape Town, Cape Town, South Africa

1 st EULAR-PreS PAED MSUS Course Intermediate

The Melbourne Clinical Gait Course, 2018

Epigenetic programming in chronic lymphocytic leukemia

Genome. Institute. GenomeVIP: A Genomics Analysis Pipeline for Cloud Computing with Germline and Somatic Calling on Amazon s Cloud. R. Jay Mashl.

The lymphoma-associated NPM-ALK oncogene elicits a p16ink4a/prb-dependent tumor-suppressive pathway. Blood Jun 16;117(24):

EASL HCC SUMMIT 2018 FROM BASIC TO CLINICAL RESEARCH: HOW TO IMPROVE HCC CLINICAL CARE? 01 03, MARCH 2018 GENEVA, SWITZERLAND

1 st South American Workshop on Genomics and Community Genetics

WHAT IS THE DECISION MAKING PROCESS?

VIRUSES AND BREAST CANCER

08:45-09:00 Dr. Eiman Mustafawi Dean, College of Arts and Sciences, Qatar University

Strasbourg, 4-7 July Scientific Programme

American Society for Reproductive Immunology 2nd Clinical Reproductive Immunology Symposium

PROGRAM: SLTBR Meeting Location: Centre Mont-Royal, 2200 rue Mansfield, Montréal, H3A 3R8

Professor of Medicine, Johns Hopkins Bloomberg School of Public Health; Director, Johns Hopkins Center for Global Health, Baltimore, MD

EPNV-Montreux 2018: Preliminary Educational and Scientific Program

SINGAPORE. 12 th PVRI Annual World Congress. on Pulmonary Vascular Disease WELCOME TO. Date // January 2018

EULAR-PReS PAEDIATRIC MUSCULOSKELETAL COURSE. Monday 12th Wednesday 14th June 2017 Madrid, Spain

11th AACR JCA Joint Conference on Breakthroughs in Cancer Research:Biology to Precision Medicine

Sunday, March 22, 2015

SESSION 1: IMMUNE CHECKPOINTS: MECHANISMS AND THERAPEUTIC OPPORTUNITIES Grand Ballroom I/II

Safety Pharmacology Post Meeting Survey 2014

Cancer gene discovery via network analysis of somatic mutation data. Insuk Lee

8 th Sonography Course Ultrasound Trainers [Teach the Teachers, TTT]

Stryker-ALPS Shoulder Arthroscopy Course

PRE-CONFERENCE ACTIVITIES TUESDAY 4 TH - WEDNESDAY 5 TH SEPTEMBER 2018

Cardio Pulmonary Exercise Testing Course 31 st October 2 nd November 2016

Epigenomics of Common Diseases

Determinants of response and resistance in drug discovery and development Tona M. Gilmer

Sunday, April 6 th. How to Read a Map: Understanding Structure-Function Relationships in the Brain. 3:00 pm Check-in. 6:00 pm Reception (Lobby)

7:00 p.m.-7:15 p.m. Welcome Frank McCormick, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

ADVANCES IN SKELETAL MUSCLE BIOLOGY IN HEALTH AND DISEASE CONFERENCE PROGRAM

Sponsorship Packages. Sunday, May 6th - Wednesday, May 9th. Fairmont Scottsdale Princess Scottsdale, AZ

Transcription:

Programme Sunday 05 November 2017 11:15-13:15 Arrival / Registration with light refreshments ATC Reception and Foyer 13:15-13:30 Opening remarks ATC Auditorium 13:30-16:15 Session 1: Structural genomics and cancer Chairs: Peter Lichter and Peter Campbell 13:30-14:00 Advancing the field of mutational signatures: Insights into mutational mechanisms and clinical applications Serena Nik-Zainal Wellcome Trust Sanger Institute, United Kingdom 14:00-14:15 Pan-cancer analysis of whole genomes reveals driver rearrangements promoted by LINE-1 retrotransposition in human tumours 1 2 Bernardo Rodríguez-Martín CINBIO, University of Vigo, Spain 14:15-14:30 Genomic footprints of activated telomere maintenance mechanisms in cancer Lina Sieverling German Cancer Research Center, Germany 14:30-15:00 Germline determinants of the somatic mutation landscape in 2,642 cancer genomes Jan Korbel EMBL Heidelberg, Germany 3 4 15:00-15:30 Coffee Break 15:30-15:45 Inherited determinants of early recurrent somatic mutations in prostate cancer Alessandro Romanel University of Trento, Italy 5 Page 5

EMBL Conference: Cancer Genomics 15:45-16:00 Validating the concept of mutational signatures with isogenic cell models Xueqing Zou Wellcome Trust Sanger Institute, United Kingdom 16:00-16:15 Canonical fusions in bone and soft tissue cancer are generated by replication-associated genomic catastrophes 6 7 Nathaniel Anderson The Hospital for Sick Children, Canada 16:15-17:00 Coffee Break & Meet the Speakers 17:00-18:00 Keynote lecture: Peter Lichter ATC Auditorium Challenges in understanding the biological and clinical behavior of tumors on the basis of structural and functional genomics 8 Peter Lichter German Cancer Research Center, Germany 18:00-20:30 Welcome reception with light refreshments Page 6

Programme Monday 06 November 2017 09:00-12:15 Session 2: Systems biology and drivers of cancer Chairs: Núria López-Bigas and Stefan Pfister 09:00-09:30 The Genomic Landscape of Childhood Cancers and its Clinical Implications 9 Stefan M. Pfister Hopp Children s Comprehensive Cancer Center at the NCT Heidelberg (KiTZ), German Cancer Research Center (DKFZ), Heidelberg University Hospital, Germany 09:30-09:45 Pan-cancer driver discovery in more than 2,500 whole cancer genomes Jakob Skou Pedersen Aarhus University Hospital, Denmark 09:45-10:00 Identification and characterization of oncogenic SOS1 mutations in lung adenocarcinoma Diana Cai Harvard University, United States of America 10 11 10:00-10:30 To be presented onsite 12 Nuria Lopez-Bigas ICREA, Institute for Research in Biomedicine, Spain 10:30-11:00 Coffee Break 11:00-11:15 Non-coding cancer driver mutations in super-enhancers and long-range chromatin interaction networks 13 Juri Reimand Ontario Institute for Cancer Research, Canada 11:15-11:30 The evolutionary history of 2,658 cancers 14 Peter Van Loo The Francis Crick Institute, United Kingdom Page 7

EMBL Conference: Cancer Genomics 11:30-11:45 Pervasive intra-tumour heterogeneity and subclonal selection across cancer types Kerstin Haase The Francis Crick Institute, United Kingdom 11:45-12:00 Identification of non-neutral tumour evolution across human cancer types Maxime Tarabichi The Francis Crick Institute, United Kingdom 12:00-12:15 Elucidating the effects of SNPs in genotype-phenotype mappings of carcinogenesis Jimmie Haellman University of Sheffield, United Kingdom 15 16 17 12:15-13:45 Lunch 13:00-13:45 Workshop hosted by Thermo Fisher Scientific Flex Lab A+B 13:45-15:45 Poster Session I (odd numbers) ATC Helix A 15:45-16:45 Session 3: Cancer immunogenomics Chair: Lynda Chin 15:45-16:00 The pan-cancer landscape of interactions between solid tumors and infiltrating immune cell populations David Tamborero Universitat Pompeu Fabra; Institute for Research in Biomedicine, Spain 16:00-16:30 A novel mechanism of cancer immune evasion vis 3'-UTR disruption of PD-L1 Seishi Ogawa Kyoto University, Japan 18 19 Page 8

Programme 16:30-16:45 Analysis of allele specific HLA loss in lung cancer evolution 20 Rachel Rosenthal UCL Cancer Institute, United Kingdom 16:45-17:30 Coffee Break & Meet the Speakers 17:30-18:30 Keynote lecture: Alexander van Oudenaarden, ATC Auditorium Whole-organism clone-tracing using single-cell sequencing 21 Alexander van Oudenaarden Hubrecht Institute, The Netherlands 18:30-20:00 Dinner EMBL Canteen 20:00-21:30 After-dinner drinks ATC Rooftop Lounge Page 9

EMBL Conference: Cancer Genomics Tuesday 07 November 2017 09:00-12:00 Session 4: Cancer genome and epigenome Chairs: Matthew Meyerson and Elizabeth Murchison 09:00-09:30 Clarifying the impact of genetic defects in prostate cancer through epigenetics Mathieu Lupien Princess Margaret Cancer Centre, University Health Network, Canada 09:30-09:45 A pan-cancer analysis of promoter activity highlights the regulatory role of alternative transcription start sites and their association with noncoding mutations 22 23 Jonathan Goeke Genome Institute of Singapore, Singapore 09:45-10:00 Mutation accumulation during human foetal development 24 Francis Blokzijl UMC Utrecht, The Netherlands 10:00-10:30 Genomic instability triggered by chromosome gains 25 Zuzana Storchova TU Kaiserslautern, Germany 10:30-11:00 Coffee Break 11:00-11:30 Mutations and their interactions in individuals 26 Ben Lehner Centre for Genomic Regulation (CRG), Spain 11:30-11:45 Identification and characterization of recurrent deletions in the human genome promoted by expression of transposase-derived gene across different tumor types 27 Elias Rodriguez-Fos Barcelona Supercomputing Center (BSC), Spain Page 10

Programme 11:45-12:00 Pan-cancer analysis of DNA replication strand asymmetry in mutational signatures Marketa Tomkova University of Oxford, United Kingdom 28 12:00-13:30 Lunch 13:30-15:30 Poster Session II (even numbers) ATC Helix A 15:30-18:30 Session 5: Cancer genome medicine Chair: Mathieu Lupien 15:30-16:00 To be presented onsite 29 Lynda Chin Institute for Health Transformation, University of Texas System, United States of America 16:00-16:15 The TARGET pilot study of a comprehensive precision medicine platform for children with high-risk cancer Emily Mould Children's Cancer Institute, Australia 16:15-16:45 Integrative Literature Mining and Knowledge Networks for Kinase Cancer Drug Analytics Cathy Wu University of Delaware, United States of America 30 31 16:45-17:30 Coffee Break & Meet the Speakers 17:30-17:45 Establishment and characterization of an ovarian cancer organoid biobank Jose Espejo Valle-Inclan University Medical Center Utrecht, The Netherlands 32 17:45-18:00 Mapping the evolution of carboplatin resistance in ovarian cancer with single cell sequencing Olivier Harismendy University of California, San Diego, United States of America 33 Page 11

EMBL Conference: Cancer Genomics 18:00-18:30 To be presented onsite 34 Jessica Zucman-Rossi Inserm, France 18:30-20:30 Banquet Dinner EMBL Canteen 20:30-00:00 Conference Party with DJ Page 12

Programme Wednesday 08 November 2017 09:00-12:00 Session 6: The future of cancer genomics Chair: Zuzana Storchova and Jan Korbel 09:00-09:30 Interrogating the architecture of cancer genomes 35 Peter Campbell Wellcome Trust Sanger Institute, United Kingdom 09:30-09:45 Copy number signatures across primary tumours 36 Tauanne Amarante Wellcome Trust Sanger Institute, United Kingdom 09:45-10:15 Two transmissible cancers in Tasmanian devils 37 Elizabeth Murchison University of Cambridge, United Kingdom 10:15-10:30 Somatic variation and mutagenesis in a canine transmissible cancer Adrian Baez-Ortega University of Cambridge, United Kingdom 38 10:30-11:00 Coffee Break & Meet the Speakers 11:00-11:15 Tumor heterogeneity over time in zebrafish using single-cell RNA-Seq Itai Yanai New York University Langone Health, United States of America 39 11:15-11:30 High density of cancer mutations in normal oesophagus 40 Inigo Martincorena Wellcome Trust Sanger Institute, United Kingdom 11:30-12:00 Genomic analysis of human cancers 41 Matthew Meyerson Dana-Farber Cancer Institute and Harvard Medical School, United States of America Page 13

EMBL Conference: Cancer Genomics 12:00-12:10 Closing remarks ATC Auditorium 12:10-12:30 Packed lunch & Departures Please remember to collect your poster. Posters that have not been collected will be disposed of after the meeting. Check your inbox when the meeting ends. You will find an email with the link to the online feedback questionnaire. Please take time to complete it. Page 14